Enliven Therapeutics shares owned by Capstone Investment Advisors
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Capstone Investment Advisors
from 13F filings
Historical chart of Capstone Investment Advisors investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by Capstone Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enliven Therapeutics by Capstone Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $537k | 11k | 50.75 |
More positions owned by Capstone Investment Advisors
View all positions for Capstone Investment Advisors